A detailed history of Apella Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Apella Capital, LLC holds 3,369 shares of EW stock, worth $291,418. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,369
Previous 2,172 55.11%
Holding current value
$291,418
Previous $207,000 50.24%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

BUY
$84.3 - $94.31 $100,907 - $112,889
1,197 Added 55.11%
3,369 $311,000
Q1 2024

Apr 10, 2024

BUY
$72.54 - $95.56 $157,556 - $207,556
2,172 New
2,172 $207,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $53.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Apella Capital, LLC Portfolio

Follow Apella Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.